MNKD · Mannkind Corp
United States · RS rating 46 · As of 2026-11-03
| Price | 3.73 USD |
|---|---|
| 1-day change | +2.2% |
| RS rating (overall / 1M / 3M / 12M) | 46 / 51 / 48 / 29 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 27 / 16 / 19 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +36.3% |
| Distance from 52-week high | +39.9% |
| Market cap (USD) | $836.8M |